Expressiona and Diagnostic Potential of miRNAs in NSCLC

The Expression Profiling of Serum miRNAs (106b-5p, 601, and 760) in Non-small Cell Lung Cancer Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05815407

Enrollment

100

Registered

2023-04-18

Start date

2018-09-01

Completion date

2022-09-30

Last updated

2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Brief summary

Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients

Detailed description

A retrospective observational study on NSCLC patients, to determine the serum expression levels if some miRNAs in NSCLC patients and to find if having proper diagnostic and prognostic values in early disease detection, and/or staging.

Interventions

OTHERNo intervention

No intervention

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* First time and recently diagnosed NSCLC patient

Exclusion criteria

* Recurrent NSCLC * Start of chemotherapy, radiotherapy or surgical intervention * Previous treatment * Cancer history

Design outcomes

Primary

Measure	Time frame	Description
Determination of the expression	By the end of the study (September 2022)	Expression profiling of the selected miRNAs

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026